"Bone Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer located in bone tissue or specific BONES.
Descriptor ID |
D001859
|
MeSH Number(s) |
C04.588.149 C05.116.231
|
Concept/Terms |
Bone Neoplasms- Bone Neoplasms
- Bone Neoplasm
- Neoplasm, Bone
- Neoplasms, Bone
|
Below are MeSH descriptors whose meaning is more general than "Bone Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Bone Neoplasms".
This graph shows the total number of publications written about "Bone Neoplasms" by people in this website by year, and whether "Bone Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 0 | 1 |
1996 | 1 | 0 | 1 |
1998 | 2 | 0 | 2 |
1999 | 4 | 0 | 4 |
2000 | 4 | 0 | 4 |
2001 | 5 | 3 | 8 |
2002 | 3 | 1 | 4 |
2003 | 5 | 2 | 7 |
2004 | 6 | 5 | 11 |
2005 | 9 | 2 | 11 |
2006 | 7 | 1 | 8 |
2007 | 3 | 3 | 6 |
2008 | 4 | 1 | 5 |
2009 | 4 | 0 | 4 |
2010 | 6 | 3 | 9 |
2011 | 8 | 6 | 14 |
2012 | 5 | 2 | 7 |
2013 | 5 | 2 | 7 |
2014 | 7 | 1 | 8 |
2015 | 8 | 0 | 8 |
2016 | 2 | 0 | 2 |
2017 | 6 | 2 | 8 |
2018 | 8 | 0 | 8 |
2019 | 3 | 1 | 4 |
2020 | 7 | 1 | 8 |
2021 | 4 | 0 | 4 |
2022 | 4 | 1 | 5 |
2023 | 5 | 0 | 5 |
2024 | 4 | 0 | 4 |
2025 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Bone Neoplasms" by people in Profiles.
-
Identifying consensus and areas for future research in chondrosarcoma : a report from the Birmingham Orthopaedic Oncology Meeting. Bone Joint J. 2025 Feb 01; 107-B(2):246-252.
-
High-quality expert annotations enhance artificial intelligence model accuracy for osteosarcoma X-ray diagnosis. Cancer Sci. 2024 Nov; 115(11):3695-3704.
-
Breast cancer exploits neural signaling pathways for bone-to-meninges metastasis. Science. 2024 Jun 21; 384(6702):eadh5548.
-
Cell Cycle Checkpoints p16 and p21-Strong Predictors of Clinicopathologic Outcomes in High-Grade Osteosarcoma. Cancer J. 2024 May-Jun 01; 30(3):133-139.
-
Controversies in orthopaedic oncology. Bone Joint J. 2024 05 01; 106-B(5):425-429.
-
Determinants of Bone-Modifying Agent Prescribing for Metastatic Castration-Resistant Prostate Cancer in a National Health Care Delivery System. JCO Oncol Pract. 2024 01; 20(1):59-68.
-
High bone tumor burden to identify advanced non-small cell lung cancer patients with survival benefit upon bone targeted agents and immune checkpoint inhibitors. Lung Cancer. 2023 12; 186:107417.
-
Clear cell chondrosarcoma: a review of clinicopathologic characteristics, differential diagnoses, and patient management. Hum Pathol. 2023 09; 139:126-134.
-
Breaking Up Isn't Hard to Do: Isolating Cell-free DNA Fragments in Osteosarcoma. Clin Cancer Res. 2023 06 01; 29(11):2017-2019.
-
Clinical Targeted Next-Generation Panel Sequencing Reveals MYC Amplification Is a Poor Prognostic Factor in Osteosarcoma. JCO Precis Oncol. 2023 03; 7:e2200334.